The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro

Anesthesia and Analgesia

Volumn 117, Issue 4, 2013, Pages 767-772

  Yee, Branden E ^a   Wissler, Richard N ^a   Zanghi, Christine N ^a   Feng, Changyong ^a   Eaton, Michael P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; DILUTION; DRUG BLOOD LEVEL; ELECTIVE SURGERY; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NEWBORN; NONHUMAN; PLACENTA; PRIORITY JOURNAL; THROMBOELASTOGRAPHY; UMBILICAL CORD;

ANTIFIBRINOLYTIC AGENTS; FETAL BLOOD; FIBRINOLYSIS; HUMANS; INFANT, NEWBORN; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84885020989     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3182a22258     Document Type: Article

References (58)

1. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004;30:1873-81 (Pubitemid 39468407)
2. Eaton MP. Antifibrinolytic therapy in surgery for congenital heart disease. Anesth Analg 2008;106:1087-100 (Pubitemid 351450530)
3. Albisetti M. The fibrinolytic system in children. Semin Thromb Hemost 2003;29:339-48
4. Kuhle S, Male C, Mitchell L. Developmental hemostasis: proand anticoagulant systems during childhood. Semin Thromb Hemost 2003;29:329-38
5. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72 (Pubitemid 17111257)
6. Ries M, Easton RL, Longstaff C, Zenker M, Corran PH, Morris HR, Dell A, Gaffney PJ. Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains. Thromb Res 2001;103:173-84 (Pubitemid 32728102)
7. Ries M, Easton RL, Longstaff C, Zenker M, Morris HR, Dell A, Gaffney PJ. Differences between neonates and adults in carbohydrate sequences and reaction kinetics of plasmin and alpha(2)-antiplasmin. Thromb Res 2002;105:247-56 (Pubitemid 34260948)
8. Parmar N, Albisetti M, Berry LR, Chan AK. The fibrinolytic system in newborns and children. Clin Lab 2006;52:115-24
9. Bulutcu FS, Ozbek U, Polat B, Yalçin Y, Karaci AR, Bayindir O. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Paediatr Anaesth 2005;15:41-6 (Pubitemid 40188791)
10. Chauhan S, Bisoi A, Modi R, Gharde P, Rajesh MR. Tranexamic acid in paediatric cardiac surgery. Indian J Med Res 2003;118:86-9 (Pubitemid 37493015)
11. Levin E, Wu J, Devine DV, Alexander J, Reichart C, Sett S, Seear M. Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000;83:54-9 (Pubitemid 30045477)
12. Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997;84:990-6 (Pubitemid 27197656)
13. Zonis Z, Seear M, Reichert C, Sett S, Allen C. The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1996;111:982-7 (Pubitemid 26146052)
14. Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology 2013;118:853-62
15. Andersson L, Nilsoon IM, Colleen S, Granstrand B, Melander B. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann N Y Acad Sci 1968;146:642-58
16. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006;4:411-6
17. Gallimore MJ, Harris SL, Tappenden KA, Winter M, Jones DW. Urokinase induced fibrinolysis in thromboelastography: a model for studying fibrinolysis and coagulation in whole blood. J Thromb Haemost 2005;3:2506-13 (Pubitemid 41727168)
18. Nielsen VG, Cohen BM, Cohen E. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagul Fibrinolysis 2006;17:75-81 (Pubitemid 43170759)
19. Nielsen VG, Cankovic L, Steenwyk BL. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered? Blood Coagul Fibrinolysis 2007;18:35-9 (Pubitemid 46006271)
20. Yurka HG, Wissler RN, Zanghi CN, Liu X, Tu X, Eaton MP; Congenital Heart Surgery Research Interest Group. The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro. Anesth Analg 2010;111:180-4
21. Koster A, Börgermann J, Zittermann A, Lueth JU, Gillis-Januszewski T, Schirmer U. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth 2013;110:34-40
22. Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012;93:148-54
23. Breuer T, Martin K, Wilhelm M, Wiesner G, Schreiber C, Hess J, Lange R, Tassani P. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Eur J Cardiothorac Surg 2009;35:167-71; author reply 171
24. Hocker JR, Saving KL. Fatal aortic thrombosis in a neonate during infusion of epsilon-aminocaproic acid. J Pediatr Surg 1995;30:1490-2
25. Fanashawe MP, Shore-Lesserson L, Reich DL. Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest. Anesthesiology 2001;95:1525-7 (Pubitemid 33126768)
26. Neter J, Kutner M, Nachtsheim W, Wasserman C. Applied Linear Statistical Models. 4th ed. New York, NY: McGraw-Hill/ Irwin, 1996
27. Van der Vaaart AW. Asymptotic Statistics. New York, NY: Cambridge University Press, 1998
28. Chan KL, Summerhayes RG, Ignjatovic V, Horton SB, Monagle PT. Reference values for kaolin-activated thromboelastography in healthy children. Anesth Analg 2007;105:1610-3, table of contents (Pubitemid 350190554)
29. Jaggers JJ, Neal MC, Smith PK, Ungerleider RM, Lawson JH. Infant cardiopulmonary bypass: a procoagulant state. Ann Thorac Surg 1999;68:513-20 (Pubitemid 29521102)
30. Miller BE, Guzzetta NA, Tosone SR, Levy JH. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000;90:1324-30 (Pubitemid 30351330)
31. Pet?j? J, Peltola K, Sairanen H, Leijala M, Kekomäki R, Vahtera E, Siimes MA. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. J Thorac Cardiovasc Surg 1996;112:665-71 (Pubitemid 26347021)
32. Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 1989;3:181-8 (Pubitemid 19098790)
33. Chauhan S, Das SN, Bisoi A, Kale S, Kiran U. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004;18:141-3 (Pubitemid 38506857)
34. Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg 2000;70:1308-12
35. McClure PD, Izsak J. The use of epsilon-aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease. Anesthesiology 1974;40:604-8
36. Rao BH, Saxena N, Chauhan S, Bisoi AK, Venugopal P. Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. Indian J Med Res 2000;111:57-61 (Pubitemid 30245600)
37. Williams GD, Bratton SL, Riley EC, Ramamoorthy C. Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1999;13:304-8 (Pubitemid 29283382)
38. Chauhan S, Bisoi A, Kumar N, Mittal D, Kale S, Kiran U, Venugopal P. Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2004;12:121-4 (Pubitemid 39010972)
39. Giordano R, Palma G, Poli V, Palumbo S, Russolillo V, Cioffi S, Mucerino M, Mannacio VA, Vosa C. Tranexamic acid therapy in pediatric cardiac surgery: a single-center study. Ann Thorac Surg 2012;94:1302-6
40. Shimizu K, Toda Y, Iwasaki T, Takeuchi M, Morimatsu H, Egi M, Suemori T, Suzuki S, Morita K, Sano S. Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial. J Anesth 2011;25:823-30
41. Varela Crespo CA, Sanabria Carretero P, Palomero Rodríguez MA, Tormo las de Heras C, Rodríguez Pérez E, Goldman Tarlousky L. Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery. Rev Esp Anestesiol Reanim 2007;54:155-61
42. Glick R, Green D, Ts'ao C, Witt WA, Yu AT, Raimondi AJ. High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. Neurosurgery 1981;9:398-401 (Pubitemid 11018518)
43. Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010;110:350-3
44. Iplikcioglu AC, Berkman MZ. The effect of short-term antifibrinolytic therapy on experimental vasospasm. Surg Neurol 2003;59:10-6; discussion 16-7 (Pubitemid 36299097)
45. Tsementzis SA, Meyer CH, Hitchcock ER. Cerebral blood flow in patients with a subarachnoid haemorrhage during treatment with tranexamic acid. Neurochirurgia (Stuttg) 1992;35:74-8
46. Furtmüller R, Schlag MG, Berger M, Hopf R, Huck S, Sieghart W, Redl H. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid (A) receptor antagonistic effect. J Pharmacol Exp Ther 2002;301:168-73 (Pubitemid 34256345)
47. Lecker I, Wang DS, Romaschin AD, Peterson M, Mazer CD, Orser BA. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 2012;122:4654-66
48. Rappaport LA, Wypij D, Bellinger DC, Helmers SL, Holmes GL, Barnes PD, Wernovsky G, Kuban KC, Jonas RA, Newburger JW. Relation of seizures after cardiac surgery in early infancy to neurodevelopmental outcome. Boston Circulatory Arrest Study Group. Circulation 1998;97:773-9 (Pubitemid 28135340)
49. Eriksson O, Kjellman H, Pilbrant A, Schannong M. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol 1974;7:375-80
50. Andersson L, Eriksson O, Hedlund PO, Kjellman H, Lindqvist B. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Urol Res 1978;6:83-8 (Pubitemid 8326077)
51. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002;97:390-9 (Pubitemid 34847752)
52. Nuttall GA, Gutierrez MC, Dewey JD, Johnson ME, Oyen LJ, Hanson AC, Oliver WC Jr. A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery. J Cardiothorac Vasc Anesth 2008;22:230-5 (Pubitemid 351423688)
53. Soslau G, Horrow J, Brodsky I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991;38:113-9
54. Fichera C, Ferrauto A. On the antifibrinolytic activity of 6-aminocaproic acid (6-ACA). Thromboelastographic observations. Boll Soc Ital Biol Sper 1961;37:1174-6
55. Edwards RM, Naik-Mathuria BJ, Gay AN, Olutoye OO, Teruya J. Parameters of thromboelastography in healthy newborns. Am J Clin Pathol 2008;130:99-102
56. Ekert H, Sheers M. Pre-and post-operative studies of fibrinolysis and prothrombin in cyanotic congenital heart disease. Haemostasis 1974;3:158-66
57. Miller BE, Guzzetta NA, Tosone SR, Miller JL, Flunker AR, Silvey EM, Levy JH. Tissue factor-activated thromboelastograms in children undergoing cardiac surgery: baseline values and comparisons. Anesth Analg 2003;97:1289-93 (Pubitemid 37310121)
58. Eisses MJ, Chandler WL. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children. J Cardiothorac Vasc Anesth 2008;22:53-9 (Pubitemid 351179393)